General News

Johnson & Johnson notches 11% sales growth in Q3


Johnson & Johnson’s sales revenue climbed in the latest quarter, with $502 million in global Covid-19 vaccine sales buoying double-digit growth in the pharmaceutical division, according to…



Click here to view the original article.

Related Posts

You might also like ...